A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus

Oral Diseases

Volumn 15, Issue 2, 2009, Pages 162-169

  González Moles, Ma ^a   Esteban, F ^b   Ruiz Avila I ^c   Gil Montoya, Ja ^a   Brener, S ^a   Bascones Martinez A ^d   Munoz M ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^c Pathology Department   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Malignant transformation; NK 1 receptor; Oral lichen planus; Substance P

Indexed keywords

CASPASE 3; CASPASE 3 INHIBITOR; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR ANTAGONIST; SUBSTANCE P; SUBSTANCE P ANTIBODY;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION;

ADULT; AGED; ANALYSIS OF VARIANCE; APOPTOSIS; CASE-CONTROL STUDIES; CASPASE 3; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS, ORAL; MIDDLE AGED; MOUTH MUCOSA; RECEPTORS, NEUROKININ-1; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; SUBSTANCE P;

EID: 60349115488     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2008.01504.x     Document Type: Article

References (53)

1. Balkwill F, Mantovani A (2001). Inflammation and cancer: back to virchow? The lancet 357 : 539 545.
2. Bang R, Sass G, Kiemer AK, Vollmar AM, Neuhuber WL, Tiegs G (2003). Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury. J Pharmacol Exp Ther 305 : 31 39.
3. Bascones-Ilundain C, Gonzalez-Moles MA, Esparza G et al (2005). Apoptosis and cell cycle arrest in oral lichen planus hypothesis on their possible influence on its malignant transformation. Arch Oral Biol 50 : 873 881.
4. Bascones-Ilundain C, González-Moles MA, Esparza G, Gil-Montoya JA, Bascones-Martínez A (2006). Importance of apoptotic mechanisms in inflammatory infiltrate of oral Lichen Planus lesions. Anticancer Res 26 : 357 362.
5. Bascones-Ilundain C, Gonzalez-Moles MA, Esparza G, Gil-Montoya JA, Bascones-Martinez A (2007). Significance of liquefaction degeneration in oral lichen planus: a study of its relationship with apoptosis and cell cycle arrest markers. Clin Exp Dermatol 32 : 556 563.
6. Bloor BK, Malik FK, Odell EW, Morgan PR (1999). Quantitative assessment of apoptosis in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 : 187 195.
7. Blum AM, Metwali A, Crawford C et al (2001). Interleukin 12 and antigen independently induce substance P receptor expression in T cells in murine schistosomiasis mansoni. FASEB J 15 : 950 957.
8. Blum AM, Metwali A, Elliott DE, Weinstock JV (2003). T cell substance P receptor governs antigen-elicited IFN-gamma production. Am J Physiol Gastrointest Liver Physiol 284 : G197 G204.
9. Chaiyarit P, Ma N, Hiraku Y et al (2005). Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci 96 : 553 559.
10. Clevers H (2004). At the crossroads of inflammation and cancer. Cell 118 : 671 674.
11. Cook GA, Elliott D, Metwali A et al (1994). Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor. J Immunol 152 : 1830 1835.
12. Coussens LM, Werb Z (2002). Inflammation and cancer. Nature 420 : 860 867.
13. Culman J, Unger T (1995). Central tachykinins: mediators of defence reaction and stress reactions. Can J Physiol Pharmacol 73 : 885 891.
14. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Déry O, Bunnett NW (2000). The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. Proc Natl Acad Sci U S A 97 : 11086 11091.
15. Dekker NP, Lozada-Nur F, Lagenaur LA, MacPhail LA, Bloom CY, Regezi JA (1997). Apoptosis-associated markers in oral lichen planus. J Oral Pathol Med 26 : 170 175.
16. DeVane CL (2001). Substance P: a new era, a new role. Pharmacotherapy 21 : 1061 1069.
17. Esteban F, Muñoz M, González-Moles MA, Rosso M (2006). A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev 25 : 137 145.
18. de Felipe C, Herrero JF, O′Brien JA et al (1998). Altered nociception, analgesia and agresión in mice lacking the receptor for substance P. Nature 392 : 394 397.
19. Gonzalez-Moles MA, Scully C, Gil-Montoya JA (2008a). Oral lichen planus: controversies surrounding malignant transformation. Oral Dis 14 : 229 243.
20. González-Moles MA, Bascones-Ilundain C, Gil Montoya JA, Ruiz-Avila I, Delgado-Rodríguez M, Bascones-Martínez A (2006). Cell cycle regulating mechanisms in oral lichen planus: molecular bases in epithelium predisposed to malignant transformation. Arch Oral Biol 51 : 1093 1103.
21. González-Moles MA, Mosqueda-Taylor A, Esteban F et al (2008b). Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol. doi :.
22. Goode T, O'Connell J, Anton P et al (2000). Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut 47 : 387 396.
23. Harrison S, Geppetti P (2001). Substance P. Int J Biochem Cell Biol 33 : 555 576.
24. Keränen U, Järvinen H, Kärkkäinen P, Kiviluoto T, Kivilaakso E, Soinila S (1996a). Substance P - an underlying factor for pouchitis? Prospective study of substance P- and vasoactive intestinal polypeptide-immunoreactive innervation and mast cells. Dig Dis Sci 41 : 1665 1671.
25. Keränen U, Järvinen H, Kiviluoto T, Kivilaakso E, Soinila S (1996b). Substance P- and vasoactive intestinal polypeptide-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis. Dig Dis Sci 41 : 1658 1664.
26. Kincy-Cain T, Bost KL (1997). Substance P-induced IL-12 production by murine macrophages. J Immunol 158 : 2334 2339.
27. Koon HW, Zhao D, Na X, Moyer MP, Pothoulakis C (2004). Metalloproteinases and transforming growth factor-α mediate substance p-induced mitogen-activated protein kinase activation and proliferation in human colonocytes. J Biol Chem 279 : 45519 45527.
28. Manthy PW (1991). Substance P and the inflammatory and immune response. Ann N Y Acad Sci 632 : 263 271.
29. Marriott I, Bost KL (2000). IL-4 and IFN-gamma up-regulate substance P receptor expression in murine peritoneal macrophages. J Immunol 165 : 182 191.
30. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Bucci E (2004). Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 40 : 120 130.
31. Muñoz M, Pérez A, Coveñas R, Rosso M, Castro E (2004). Antitumoural action of L-733,060 on neuroblastoma and glioma cell lines. Arch Ital Biol 142 : 105 112.
32. Muñoz M, Rosso M, Pérez A et al (2005a). The NK1 receptor is involved in the antitumoural action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides 39 : 427 432.
33. Muñoz M, Rosso M, Pérez A et al (2005b). Antitumoral action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines. Invest Ophthalmol Vis Sci 46 : 2567 2570.
34. Muñoz M, Rosso M, Coveñas R, Montero I, González-Moles MA, Robles MJ (2007). Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumor action of its antagonist, L-732,138. Invest Ophthalmol Vis Sci 48 : 2775 2781.
35. Muñoz M, Rosso M, Aguilar FJ, González-Moles MA, Redondo M, Esteban F (2008). NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2. Invest New Drugs 26 : 111 118.
36. Neppelberg E, Johannessen AC, Jonsson R 2001). Apoptosis in oral lichen planus. Eur J Oral Sci 109 : 361 364.
37. Normark S, Nilsson C, Normark BH, Hornet MW (2003). Persistent infection with Helicobacter pylori and the development of gastric cancer. Adv Cancer Res 90 : 63 89.
38. O'Byrne KJ, Dalgleish AG (2001). Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85 : 473 483.
39. Persson-Sjögren S, Lejon K, Holmberg D, Forsgren S (2005). Expression of the NK-1 receptor on islet cells and invading immune cells in the non-obese diabetic mouse. J Autoimmun 24 : 269 279.
40. Philip M, Rowley DA, Schreiber H (2004). Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14 : 433 439.
41. Quartara L, Maggi CA (1998). The tachykinin NK1 receptor. Part II: distribution and pathophysiological roles. Neuropeptides 32 : 1 49.
42. Rojo-Moreno JL, Bagán JV, Rojo-Moreno J, Donat JS, Milián MA, Jiménez Y (1998). Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86 : 687 691.
43. Sakai K, Matsuno H, Tsuji H, Tohyama M (1998). Substance P receptor (NK1) gene expression in synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 27 : 135 141.
44. Schifter M, Jones AM, Walker DM (1998). Epithelial p53 gene expression and mutational analysis, combined with growth fraction assessment, in oral lichen planus. J Oral Pathol Med 27 : 318 324.
45. Shibutani S, Takeshita M, Grollman AP (1991). Insertion of specific bases during DNA synthesis past the oxygenation-damaged base 8-oxodG. Nature 349 : 431 434.
46. Tanda N, Mori S, Saito K, Ikawa K, Sakamoto S (2000). Expression of apoptotic signaling proteins in leukoplakia and oral lichen planus: quantitative and topographical studies. J Oral Pathol Med 29 : 385 393.
47. Taniguchi Y, Nagao T, Maeda H, Kameyama Y, Warnakulasuriya KA (2002). Epithelial cell proliferation in oral lichen planus. Cell Prolif 35 : 103 109.
48. Tobón-Arroyaye SI, Villegas-Acosta FA, Ruiz-Restrepo SM, Vieco-Durán M, Restrepo-Misas M, Londoño-López ML (2004). Expression of caspase-3 and structural changes associated with apoptotic cell death of keratincytes in oral lichen planus. Oral Dis 10 : 173 178.
49. Valente G, Pagano M, Carrozzo M et al (2001). Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution. J Oral Pathol Med 30 : 135 140.
50. Weinstock JV, Blum A, Walden T (1998). Eosinophils from granulomas in murine Schistosomiasis mansoni produce SP. J Immunol 141 : 961 966.
51. Wink DA, Mitchell JB (1998). Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 25 : 434 456.
52. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 : 1326 1331.
53. Yermilov V, Rubio J, Ohshima H (1995). Formation of 8-nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination. FEBS Lett 376 : 207 210.